New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Nuvectis Pharma, Inc.
NVCT
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

163M

Biotechnology

Next Earning date - 13 Nov 2024

163M

Biotechnology

Next Earning date - 13 Nov 2024

8.76USD
Shape0.01 ( 0.11%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

-16%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

28%

Quote Panel

Shape
Updated October 26, 2024
1W 13.91 % 1M 41.75 % 3M 34.15 % 1Y 3.79 %

Key Metrics

Shape
  • Market Cap

    163.40M


  • Shares Outstanding

    18.65M


  • Share in Float

    7.65M


  • Dividende

    0


  • Earning Date

    13 Nov 2024


  • Price Target

    8.76


  • Average Volume

    108510


  • Beta

    0.449


  • Range

    5.85-12.1


  • Industry

    Biotechnology


  • Website

    https://www.nuvectis.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

Nanx

P/S Ratio

11.82x

P/B Ratio

0.0

Debt/Equity

514.6%

Net Margin

$-1.3

EPS

How NVCT compares to sector?

P/E Ratio

Relative Strength

Shape

NVCT

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$23M

ShapeNaN%

2025-Revenue

$1.04

Shape-301%

2025-EPS

$12M

Shape348%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.42
vs -0.40

Q4.22

arrow
arrow

N/A

-0.48
vs -0.48

Q1.23

arrow
arrow

N/A

-0.27
vs -0.32

Q2.23

arrow
arrow

N/A

-0.38
vs -0.28

Q3.23

arrow
arrow

N/A

-0.37
vs -0.42

Q4.23

arrow
arrow

N/A

-0.41
vs -0.48

Q1.24

arrow
arrow

N/A

-0.25
vs -0.27

Q2.24

arrow
arrow

N/A

-0.26
vs -0.38

Q3.24

arrow
arrow

N/A

-0.25
vs -0.37

Q4.24

arrow
arrow

N/A

-0.27
vs -0.41

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

+3625%

149K  vs 4K

Q1.23

arrow
arrow

NA

4.1M  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

-2852%

-4101000.00  vs 149K

Q1.24

arrow
arrow

-100%

NA  vs 4.1M

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-29%

-0.29
vs -0.31

Q4.22

arrow
arrow

-46%

-0.46
vs -0.29

Q1.23

arrow
arrow

-33%

-0.33
vs -0.46

Q2.23

arrow
arrow

-28%

-0.28
vs -0.33

Q3.23

arrow
arrow

-35%

-0.35
vs -0.28

Q4.23

arrow
arrow

-54%

-0.54
vs -0.35

Q1.24

arrow
arrow

-30%

-0.30
vs -0.54

Q2.24

arrow
arrow

-35%

-0.35
vs -0.30

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

11

11
vs 10

10%

Q4.22

arrow
arrow

11

11
vs 11

NA

Q1.23

arrow
arrow

13

13
vs 11

18%

Q2.23

arrow
arrow

37

37
vs 13

185%

Q3.23

arrow
arrow

33

33
vs 37

-11%

Q4.23

arrow
arrow

36

36
vs 33

9%

Q1.24

arrow
arrow

40

40
vs 36

11%

Q2.24

arrow
arrow

38

38
vs 40

-5%

Earnings Growth

Latest News